Patients previously treated with hematopoietic stem cell transplant (HSCT) often develop
oral mucosal lesions. The nature of these lesions includes oral infections (viral,
fungal, or bacterial), oral graft-vs-host disease, and premalignant or malignant conditions.
Therefore, vigilant coordination of care between the oncologist and oral health specialist
are crucial for early identification and management of oral lesions. We report 7 patients
who developed isolated, deep, corrugated, painful lesions after HSCT.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2014 Published by Elsevier Inc.
